The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
08/31/2009
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
Modification 1 changes the Initial Full Proposal Date. See the attached Modification 1 to DARPA-BAA-09-69.
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
DARPA-BAA-09-69
Opportunity Category:
Discretionary
Posted Date:
Aug 31, 2009
Creation Date:
Oct 15, 2009
Original Closing Date for Applications:
Aug 30, 2010
Current Closing Date for Applications:
Aug 30, 2010
Archive Date:
Sep 30, 2010
Funding Instrument Type:
Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
30
Estimated Total Program Funding:
Award Ceiling:
Award Floor:
CFDA Number(s):
12.910
--
Research and Technology Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
DARPA - Defense Sciences Office
Description
DARPA is interested in reviewing proposals that describe innovative research towards developing and demonstrating the ability to simultaneously improve antibody stability and control antibody affinity. The goal of the Antibody Technology Program is to enable multiplexed, antibody-based biosensors that have long shelf life and operate in harsh environments that are relevant to the DoD mission.
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
